Mylan CEO presents at annual health conference

American Pharmacy News Reports | Jan 21, 2017
Mylan works around the world to provide over 7 billion people with access to high quality medicine and health care.
Mylan works around the world to provide over 7 billion people with access to high quality medicine and health care. | Contributed image
Mylan CEO Heather Bresch presented at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco.
The conference was presented via webcast on Mylan’s website, www.mylan.com/investors. An archived version is now available, and can be accessed at anytime.
A global pharmaceutical company, Mylan works around the world to provide over 7 billion people with access to high quality medicine and health care. The company has helped many obtain reliable services.
Mylan has over 2, 700 generic and branded pharmaceuticals, which include remedies for antiretroviral therapies for people suffering HIV/AIDS worldwide.
More News

Those with preexisting health conditions may experience a different immune response to the COVID-19 vaccination.

People CDC releases COVID-19 guidance for those with health conditions Jan 10, 2021

Novavax is the latest COVID-19 vaccine to enter Phase III clinical trials.

Innovation Fifth vaccine set to enter Phase III clinical trials Jan 3, 2021

Regulatory CENTENE: Completes Acquisition of PANTHERx Rare Pharmacy (PANTHERx) Dec 31, 2020

Industry News NHA: Creates Partnership, Path for Accredited Immunization Training for Pharmacy Technicians Ahead of New Vaccines Dec 31, 2020

Industry News TRANQUILMONEY: Releases PharmTracker for Independent Pharmacies, Small and Medium Pharmacy Chains Dec 26, 2020

Industry News MITSUBISHI TANABE PHARMA AMERICA: Announces Initiation of Open-Label Extension Study of Oral Edaravone in ALS Dec 22, 2020

Trending

Novavax is the latest COVID-19 vaccine to enter Phase III clinical trials.

Fifth vaccine set to enter Phase III clinical trials